Companies Dominating the Insect Cell Lines Market
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Sigma-Aldrich Corporation
- GE Healthcare Technologies Inc.
- Lonza Group
- Becton, Dickinson & Company
- HiMedia Laboratories LLC
- CellGenix GmbH
- Atlanta Biologicals Inc.
- PromoCell GmbH
- Merck
Browse Key Market Insights with Data Illustration:
In the News
- Thermo Fisher Scientific Inc. teamed up with Moderna, Inc. for the production of Spikevax, COVID-19 vaccine, and other investigational mRNA therapies in its pipeline and provide devoted capacity for lyophilized and liquid filling, among other aseptic fill-finish services.
- Merck acquired AmpTec, to enhance its capacity to create and manufacture mRNA for its clients for use in many other diseases-related vaccines, therapies, and diagnostics and to hasten the creation of new treatments for numerous more ailments.
